Neuronetics: 4Q Earnings Snapshot

March 3, 2020 GMT

MALVERN, Pa. (AP) _ Neuronetics Inc. (STIM) on Tuesday reported a loss of $7.6 million in its fourth quarter.

The Malvern, Pennsylvania-based company said it had a loss of 41 cents per share.

The medical device company focused on psychiatric disorders posted revenue of $17.4 million in the period.

For the year, the company reported that its loss widened to $29 million, or $1.58 per share. Revenue was reported as $62.7 million.

Neuronetics expects full-year revenue in the range of $69 million to $71 million.

The company’s shares closed at $2.94. A year ago, they were trading at $17.42.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on STIM at https://www.zacks.com/ap/STIM